$PTLF Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PetLife Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PetLife Pharmaceuticals, Inc.. Get notifications about new insider transactions in PetLife Pharmaceuticals, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 20 2018 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Buy | P | 4,017.00 | 305,000 | 1,225,185,000 | 1,305,000 | 1000 K to 1.3 M (+30.50 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | Chief Executive Off ... | Grant | A | 0.06 | 5,000,000 | 300,000 | 17,450,000 | 12.5 M to 17.5 M (+40.16 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | Chief Executive Off ... | Buy | J | 0.00 | 1,250,000 | 0 | 1,250,000 | 0 to 1.3 M |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | Chief Executive Off ... | Sell | J | 0.00 | 1,250,000 | 0 | 12,450,000 | 13.7 M to 12.5 M (-9.12 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Buy | J | 0.00 | 1,000,000 | 0 | 1,000,000 | 0 to 1000 K |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Sell | J | 0.00 | 1,000,000 | 0 | 1,000,000 | 2 M to 1000 K (-50.00 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Vivek Ramana | Chief Medical Offic ... | Buy | J | 0.00 | 1,000,000 | 0 | 1,000,000 | 0 to 1000 K |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Vivek Ramana | Chief Medical Offic ... | Sell | J | 0.00 | 1,000,000 | 0 | 1,000,000 | 2 M to 1000 K (-50.00 %) |
| Mar 02 2018 | PTLF | PetLife Pharmaceut ... | Vivek Ramana | Chief Medical Offic ... | Grant | A | 0.67 | 1,000,000 | 670,000 | 2,000,000 | 1000 K to 2 M (+100.00 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Option Exercise | A | 0.25 | 2,000,000 | 500,000 | 2,000,000 | |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Grant | A | 0.50 | 11,160,000 | 5,580,000 | 12,300,000 | 1.1 M to 12.3 M (+978.95 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Buy | P | 0.64 | 250,000 | 160,000 | 1,140,000 | 890 K to 1.1 M (+28.09 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Buy | P | 0.46 | 540,000 | 248,400 | 890,000 | 350 K to 890 K (+154.29 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Buy | P | 0.64 | 250,000 | 160,000 | 350,000 | 100 K to 350 K (+250.00 %) |
| Mar 27 2017 | PTLF | PetLife Pharmaceut ... | Salvagno Ralph T | CEO | Buy | P | 0.25 | 100,000 | 25,000 | 100,000 | 0 to 100 K |
| Mar 24 2017 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Grant | A | 0.50 | 9,484,555 | 4,742,278 | 9,484,555 | 0 to 9.5 M |
| Mar 24 2017 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Buy | P | 0.25 | 40,000 | 10,000 | 1,608,680 | 1.6 M to 1.6 M (+2.55 %) |
| Mar 24 2017 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Grant | A | 0.50 | 1,200,000 | 600,000 | 1,568,680 | 368.7 K to 1.6 M (+325.49 %) |
| Mar 24 2017 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Buy | P | 1.25 | 218,470 | 273,088 | 368,680 | 150.2 K to 368.7 K (+145.44 %) |
| Mar 24 2017 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Buy | P | 0.25 | 100,000 | 25,000 | 150,210 | 50.2 K to 150.2 K (+199.16 %) |
| Mar 24 2017 | PTLF | PetLife Pharmaceut ... | Campbell Vyvyan | Director | Buy | P | 0.75 | 50,210 | 37,658 | 50,210 | 0 to 50.2 K |
| Dec 18 2007 | PTLF | PetLife Pharmaceut ... | WHITE CURT C | Sell | S | 0.00 | 13,000,000 | 5,200 | 750,000 | 13.8 M to 750 K (-94.55 %) |
Page: 1